Navigation Links
Bacterial genome sheds light on synthesizing cancer-fighting compounds

Sea squirts around the world are breathing a sigh of relief, as they no longer run the risk of being harvested for their natural disease-fighting substances. Scientists recently discovered that the bacterium Prochloron didemnii, which lives symbiotically inside the sea squirt, actually produces the desired patellamides, compounds that may one day be used in cancer treatment.

Despite decades of attempts, scientists could not successfully cultivate Prochloron in the laboratory once the bacterium was isolated from the sea squirt. Because samples of Prochloron were easily contaminated with remnants of life inside its animal home, scientists couldn't tell if the bacterium or the sea squirt produced the sought-after patellamides, until now.

By searching for patellamide synthesis instructions in genomic sequences, scientists found the bacterium indeed has the necessary genes to produce these potentially important biochemicals, solving the source mystery. Knowing which genes Prochloron used for patellamide production also allowed researchers to synthesize the potentially important compounds in the lab using a so-called laboratory workhorse, the bacterium E. coli.

Scientists from The Institute for Genomic Research (TIGR), the University of Utah and the University of California, San Diego, report findings in this week's online edition of the Proceedings of the National Academy of Sciences.

"This project revealed detailed information about the metabolic capabilities of Prochloron, details that proved to be difficult to determine by other means, " said Patrick Dennis, manager for Prochloron genome sequencing at the National Science Foundation, which funded the study. "Furthermore, " he added, "by producing patellamides in the lab, the team demonstrated an important proof of principle for the biosynthesis of naturally occurring marine products."


'"/>

Source:National Science Foundation


Page: 1

Related biology news :

1. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
2. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
3. Say what? Bacterial conversation stoppers
4. Bacterial protein mimics host to cripple defenses
5. Bacterial switch gene regulates how oceans emit sulfur into atmosphere
6. Bacterial protein shows promise in treating intestinal parasites
7. Bacterial response to oxidation studied as toxin barometer
8. Bacterial walls come tumbling down
9. Man and mouse share genome structures
10. Whole genome fine map of rice completed
11. Study finds more than one-third of human genome regulated by RNA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2018)... RESEARCH TRIANGLE PARK, N.C. (PRWEB) , ... December ... ... capabilities have been enhanced through upgraded processes and the completion of a new ... Factors Evaluations with the goal of ensuring medical devices and drug delivery devices/combination ...
(Date:12/19/2018)... , ... December 19, 2018 , ... InTouchMD’s flagship product, ... products in healthcare for 2018. , PM360 is featuring the recognition in its ... and services offered to the pharmaceutical and medical device industries. , “This recognition ...
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... ... has effectively incorporated artificial intelligence into client marketing. The technology has been effective ... years, R3 Stem Cell has been working with clients nationwide on patient acquisition ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years ... 22, 2019 at 2:30pm EST will explore some of the key lessons that have ... one vendor vs. using multiple vendors, and find out how to ensure that you ...
(Date:1/10/2019)... (PRWEB) , ... January 08, 2019 , ... VGI Medical ... has become a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin ... the facet joint by utilizing a unique patented dual geometric design to limit motion ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is ... Disease. The trial took place in South Korea. , This Phase 1 ...
(Date:1/4/2019)... ... January 02, 2019 , ... ... detect precancer and cancer cells in blood, has been named as a partner ... global biotech company developing cell therapies for cancer treatment, will use CellMax Life’s ...
Breaking Biology Technology: